SCHEMBL7988747

SCHEMBL7988747

Cc1cccc(Cn2cnc3nc(-c4ccncc4)nc(O)c32)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.44
CYP11B2 P19099 3/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 2/20 0.39
FYN P06241 1/20 0.39
HPGD P15428 3/20 0.39
TSHR P16473 3/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MET P08581 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
IDE P14735 1/20 0.36
ROCK2 O75116 2/20 0.36
ROCK1 Q13464 2/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
LATS1 O95835 1/20 0.36
ALOX15 P16050 1/20 0.36
MMP13 P45452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974268 0.91 CYP11B1 (0.48) CYP11B1CYP11B2ALDH1A1LMNAHPGD
SCHEMBL7985236 0.89 LMNA (0.44) CYP11B1CYP11B2ALDH1A1LMNAHPGD
SCHEMBL7988934 0.89 CYP1A2 (0.47) CYP11B1CYP11B2ALDH1A1LMNAHPGD
SCHEMBL7988567 0.88 HPGD (0.44) CYP11B1CYP11B2ALDH1A1LMNAHPGD
SCHEMBL7974247 0.87 CYP11B1 (0.44) CYP11B1CYP11B2ALDH1A1LMNAHPGD
SCHEMBL7974267 0.87 SMN1; SMN2 (0.43) CYP11B1CYP11B2HPGDHTTSMN1; SMN2
SCHEMBL7985264 0.87 CYP11B1 (0.41) CYP11B1CYP11B2ALDH1A1LMNAHPGD
SCHEMBL7985826 0.86 NPC1 (0.41) CYP11B1CYP11B2ALDH1A1LMNAHPGD
SCHEMBL7989313 0.86 ROCK2 (0.52) ROCK2ROCK1CYP3A4CYP2D6CYP2C9
SCHEMBL7974441 0.86 GRK2 (0.43) CYP11B1CYP11B2ALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed